NIH Director Collins Says Comparative Effectiveness Research Will Fall Short Without Genetic Strategies
October 28, 2009
NIH Director Collins Says Comparative Effectiveness Research Will Fall Short Without Genetic Strategies
"We need to be mindful of the goal of comparative effectiveness research and not lose all that we have gained in understanding how individuals differ and how that could be factored into better diagnostics and preventive strategies," Collins said at a colloquium on personalized medicine hosted by AAAS.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- NIH Director Collins Warns Against Comparative Effectiveness Research Without Genetic Strategies
October 28, 2009 / Pharmacogenomics Reporter - GenomeWeb Feature: The Rise of Lung Cancer Genetic Testing
May 8, 2013 / Pharmacogenomics Reporter - TCGA Study Shows Molecular Subtypes May Better Stratify Endometrial Cancer Patients than Histology
May 1, 2013 / Pharmacogenomics Reporter - Amplion Research Report Suggests Review Times Longer, Approvals Fewer for MDx over 10 Years
April 17, 2013 / Pharmacogenomics Reporter - New Weill Cornell Precision Medicine Institute Plans to Offer Genomically Guided Treatment after CLIA Approval
February 6, 2013 / Pharmacogenomics Reporter